Cargando…
Correction: Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity
Correction for ‘Novel valdecoxib derivatives by ruthenium(ii)-promoted 1,3-dipolar cycloaddition of nitrile oxides with alkynes – synthesis and COX-2 inhibition activity’ by Silvia Roscales et al., Med. Chem. Commun., 2018, DOI: 10.1039/c7md00575j.
Autores principales: | Roscales, Silvia, Bechmann, Nicole, Weiss, Daniel Holger, Köckerling, Martin, Pietzsch, Jens, Kniess, Torsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royal Society of Chemistry
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6144543/ https://www.ncbi.nlm.nih.gov/pubmed/30288211 http://dx.doi.org/10.1039/c8md90011f |
Ejemplares similares
-
Radiolabeled COX-2 Inhibitors for Non-Invasive Visualization of COX-2 Expression and Activity — A Critical Update
por: Laube, Markus, et al.
Publicado: (2013) -
Nitrile Oxide, Alkenes, Dipolar Cycloaddition, Isomerization and Metathesis Involved in the Syntheses of 2-Isoxazolines
por: Krompiec, Stanisław, et al.
Publicado: (2023) -
Understanding the 1,3‐Dipolar Cycloadditions of Allenes
por: Yu, Song, et al.
Publicado: (2020) -
Development of Antioxidant COX-2 Inhibitors as Radioprotective Agents for Radiation Therapy—A Hypothesis-Driven Review
por: Laube, Markus, et al.
Publicado: (2016) -
On-Surface Azide–Alkyne Cycloaddition Reaction:
Does It Click with Ruthenium Catalysts?
por: Li, Tiexin, et al.
Publicado: (2022)